NCT01371981

Clinical Trial Information


Trial Number: NCT01371981 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Leukemia - Acute Myeloid Leukemia
Trial Title:
A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD
Study ID:
AAML1031
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT01371981-D4 NCT01371981 – D4 Dataset

As of April 2020, there is one dataset associated with this publication (PMID 32029509). The D4 dataset is a patient level dataset which contains patient characteristics, consort diagram classifications, toxicity and outcome analyses in the manuscript for eligible pediatric acute myeloid leukemia (AML) patients enrolled on the AAML1031 clinical trial.